Study to Assess Efficacy and Safety of Three Oral Doses of Laquinimod

- Huntington's Disease
- Completed

Study Title: A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod

Teva Identifier: TV5600-CNS-20007 | 2014-000418-75

ClinicalTrials.gov Identifier: NCT02215616

Study Status: Completed

Trial Condition(s): Huntington's Disease

Interventions: Drug: Laquinimod | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult

Age Range: 21 Years to 55 Years

Trial Duration: October 28, 2014 - June 19, 2018

Phase: Phase 2

Study Type

Interventional